David R. Epstein, Director at Rubius Therapeutics, Inc. (RUBY), sold 53,408 shares at $14.93 ($797K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $797k RUBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.93 | 26,704 | $399K | 50.0% |
| 2 | $14.93 | 26,704 | $399K | 50.0% |
| Total | $14.93 avg | 53,408 | $797K | 100% |
| Filing → |
| TEM | SELL | 2026-06-03 | $12K | — | Filing → |
| TEM | SELL | 2026-03-04 | $13K | — | Filing → |
| TEM | SELL | 2026-02-04 | $22K | — | Filing → |